US Patent
US9669974 — Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids
Formulation · Assigned to Aptar Radolfzell GmbH · Expires 2034-05-11 · 8y remaining
Vulnerability score
42/100
Strong — defensible against typical IPR challenges
What this patent protects
This patent protects a protective cap for a dispenser that discharges pharmaceutical and/or cosmetical liquids.
USPTO Abstract
The invention relates to a protective cap for a dispenser, and to a dispenser for discharging pharmaceutical and/or cosmetical liquids, wherein the dispenser has a liquid reservoir and an outlet opening through which the liquid can be discharged into a surrounding atmosphere. The protective cap comprises an outer cap and an inner element inserted therein, wherein either at least one ventilation channel, which can be closed by means of a shut-off element and provides communication between an interior of the protective cap and an external environment, is formed between the outer cap and the inner element, or the inner element closes a ventilation opening of the outer cap.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.